Stock Events

Stock Events

CURRENC Group 

$2.92
0
+$0.16+5.8% 20:44 Today

Statistics

Day High
2.92
Day Low
2.76
52W High
2.92
52W Low
2.6
Volume
-
Avg. Volume
-
Mkt Cap
327.86M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10AugExpected
Q1 2026
Next
-0.11
0.22
0.56
0.89
Expected EPS
N/A
Actual EPS
N/A

Financials

-85.01%Profit Margin
Unprofitable
2021
2022
2023
2024
46.44MRevenue
-39.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CURR.CRYPTO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Avenir, making them direct competitors in the healthcare market.
AMGEN
AMGN
Mkt Cap201.93B
Amgen is a biotech firm focusing on novel therapies, including treatments for conditions that Avenir Wellness Solutions also targets.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a large pharmaceutical company with a diverse product portfolio that includes medications in direct competition with those of Avenir Wellness Solutions.
Merck
MRK
Mkt Cap319.99B
Merck operates globally in pharmaceuticals, including areas like immunotherapy and oncology, competing with Avenir's product lines.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie offers a range of biopharmaceuticals that directly compete with Avenir Wellness Solutions in multiple therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb, with its broad range of pharmaceutical products, competes in the same market segments as Avenir Wellness Solutions.
Lilly(Eli) &
LLY
Mkt Cap1.08T
Eli Lilly and Company produces medicines in areas such as mental health and diabetes, overlapping with Avenir's market interests.
Novartis
NVS
Mkt Cap305.1B
Novartis is a global healthcare company that produces drugs that directly compete with Avenir Wellness Solutions' offerings.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson has a large portfolio of pharmaceuticals that includes competitive products in the wellness and therapeutic sectors targeted by Avenir.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in areas like immunology and oncology, which are key focus areas for Avenir Wellness Solutions.

Listings

COINMARKETCAP
CRYPTO
CURR.CRYPTO
OTC Link
US
AVRW
XNAS
US
CURR

0 Comments

Share your thoughts

FAQ

What is CURRENC Group stock price today?▼
The current price of CURR.CRYPTO is $2.92 USD — it has increased by +5.8% in the past 24 hours. Watch CURRENC Group stock price performance more closely on the chart.
What is CURRENC Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Coinmarketcap exchange CURRENC Group stocks are traded under the ticker CURR.CRYPTO.
What is CURRENC Group market cap?▼
Today CURRENC Group has the market capitalization of 327.86M
When is the next CURRENC Group earnings date?▼
CURRENC Group is going to release the next earnings report on August 10, 2026.
What is CURRENC Group revenue for the last year?▼
CURRENC Group revenue for the last year amounts to 46.44M USD.
What is CURRENC Group net income for the last year?▼
CURR.CRYPTO net income for the last year is -39.48M USD.
How many employees does CURRENC Group have?▼
As of July 08, 2026, the company has 11 employees.
In which sector is CURRENC Group located?▼
CURRENC Group operates in the Health & Wellness sector.
When did CURRENC Group complete a stock split?▼
CURRENC Group has not had any recent stock splits.
Where is CURRENC Group headquartered?▼
CURRENC Group is headquartered in Sherman Oaks, United States.